5 Hot Healthcare Stocks to Buy Now

2. Ginkgo Bioworks Holdings, Inc. (NYSE:DNA)

Number of Hedge Fund Holders: 24    

YTD Perf: 15.83%

Avg Volume: 23M

Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) develops platforms for cell programming. On January 18, the Ukraine Ministry of Health’s Public Health Center teamed up with Ginkgo Bioworks to run a pilot program for testing wastewater in Ukraine. The goal of the pilot program for monitoring pathogens in wastewater is to meet essential public health requirements and give early warning signs for outbreaks of infectious diseases.

On November 28, 2022, Berenberg analyst Gaurav Goparaju initiated coverage of Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) stock with a Buy rating and a $6 price target.

At the end of the third quarter of 2022, 24 hedge funds in the database of Insider Monkey held stakes worth $956 million in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA), compared to 29 in the preceding quarter worth $575.8 million.